Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 16/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 14/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9963391 | 0.84 | ADH1B (0.39) | ADH1BADH1CADH1A | |
| SCHEMBL23368252 | 0.81 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL25075545 | 0.78 | ADH1A (0.46) | ADH1BADH1CADH1A | |
| SCHEMBL13397254 | 0.77 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3NOS3NOS1 | |
| SCHEMBL5646119 | 0.75 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3NOS3NOS1 | |
| SCHEMBL12250815 | 0.74 | ADH1A (0.54) | ADH1BADH1CADH1A | |
| SCHEMBL4593257 | 0.73 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3NOS3NOS1 | |
| Hydrochloric Acid SCHEMBL28747733 | 0.73 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3NOS3NOS1 | |
| SCHEMBL13397409 | 0.72 | ADH1B (0.32) | ADH1BADH1CADH1A | |
| SCHEMBL1009314 | 0.70 | SLC6A2 (0.32) | SLC6A2SLC6A4SLC6A3NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100104659-A1 | BENZOPYRANOPYRAZOLES | 4SC AG (DE) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104659-A1 | BENZOPYRANOPYRAZOLES | BAX, BCL2, BAD | SLC6A2 4862/4885SLC6A4 4793/4885SLC6A3 4769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.